Does Prime Therapeutics Cover Wegovy? 2026 PA Rules, Real Cost & How to Check

Prime Therapeutics is a pharmacy benefit manager (PBM), not necessarily the company providing your medical insurance. It administers drug lists and pharmacy claims under the benefit selected by your plan sponsor. Two members with Prime on their cards can have different benefits. The published Choice program explicitly warns that coverage and formularies vary by benefit plan.

What each MyPrime result means

• Covered, no PA shown: confirm the indication, product, network, and cost before filling; the display is not a payment guarantee.
• PA required: the prescriber must request approval; meeting a checklist does not guarantee the decision.
• Covered but expensive: ask about deductible, tier, and coinsurance. Manufacturer savings have separate eligibility and terms.
• Non-formulary: ask whether an individual-drug exception exists.
• Category excluded: ask for the benefit wording and applicable review rights. An ordinary PA does not add a benefit the plan omitted.

1. Open MyPrime. Sign in for your member-specific information, or select your exact plan and drug list if using a guest search.
2. Search the exact product: Wegovy autoinjector pens and Wegovy tablets may have different coverage.
3. Save the coverage status, tier, PA requirement, step therapy, quantity limit, and estimated cost. MyPrime estimates are not the final pharmacy price.
4. Call the pharmacy-benefits or Member Services number on your card. Generic website/account support is not the same as a benefits team that can confirm coverage. If referred elsewhere, ask who owns the decision and request a reference number.

Ro’s free GLP-1 Insurance Coverage Checker contacts insurance and returns a report for supported medications. The October 1 source check confirms support for Wegovy autoinjector pens, not the Wegovy pill. The free check does not submit treatment requests or write prescriptions and is not an approval guarantee.

Affiliate link. New Ro account required. You can check directly with MyPrime and your plan instead.

Your prescriber documents the reason for treatment and requests approval when the plan requires it. The table uses the Choice commercial program PDF effective July 1, 2026 as a published example, not a rule for all Prime plans. Confirm the applicable policy and benefit before submitting. Separate indications can require separate documentation.

Prescriber documentation checklist

• Exact product, dose, diagnosis, member information, and plan-specific form or electronic route.
• Baseline and current height/weight/BMI; pediatric percentile records when applicable.
• Chart notes for qualifying conditions, lifestyle efforts, previous treatments, and any required step therapy.
• Medication list and contraindication review, with indication-specific cardiovascular or liver records when needed.
• For renewal, the prior authorization expiration date, starting and current weight, dose history, and required response evidence.

Where do I get the form?

Ask your pharmacy-benefits team or use your plan’s MyPrime information to identify the correct request form. Your prescriber submits the request, using the plan’s form or approved electronic route. A public policy PDF explains criteria; it is not a completed request. Incomplete submissions may be returned for additional information.

Quantity limits: Choice commercial program example

The Choice commercial program PDF effective July 1, 2026 lists these limits: 60 tablets per 180 days for 1.5 mg, 4 mg, and 9 mg; 30 tablets per 30 days for 25 mg; 8 pens per 180 days for 0.25 mg, 0.5 mg, and 1 mg autoinjectors; and 4 pens per 28 days for 1.7 mg and 2.4 mg autoinjectors. These are not universal Prime limits. Confirm your exact product and dose with your plan. A quantity-limit rejection differs from an exclusion: ask your prescriber and pharmacist to check the fill history, dose, and whether a quantity-limit exception is available.

There is no single Prime price. Your medication cost depends on the covered product, authorization, pharmacy network, tier, copay or coinsurance, and deductible. Ask for an in-network estimate for your next fill, including whether it is before or after the deductible. A covered prescription can still be expensive while you are meeting a deductible; an approved PA does not promise a low copay.

If eligible, manufacturer savings may reduce your cost, but the terms and government-program exclusions must be checked directly. Our older medication prices and savings amounts were not reverified for this merger, so we do not present them as current quotes. Check NovoCare’s current Wegovy options and terms for manufacturer self-pay offers. Your actual medication price is unknown until your plan, pharmacy, or the applicable program quotes it.

Medication price is separate from a telehealth membership. A membership pays for services such as clinical care or administrative support; it is not the pharmacy copay. Budget for both if using a paid care program. Ro’s verified membership rates and the direct-prescriber tradeoff are explained in the provider-fit section below.

Get the denial or pharmacy rejection in writing, along with the policy, failed criterion, and deadline. A national formulary listing does not prove your benefit is present. A price estimate is also different from a coverage denial.

Appeal routes and deadlines

Follow the denial notice for internal appeal instructions, submission address, and deadline. Your prescriber can explain the medical reasoning and supply supporting records. Ask the plan whether a formulary or quantity-limit exception is the correct route instead of repeating the same PA. If an internal appeal is upheld, ask whether you qualify for external review. Rights differ by plan and type of denial; no appeal outcome is guaranteed.

First separate an individual drug’s formulary exclusion from a whole category benefit exclusion. Ask for the written benefit and any exception or review rights. You can also ask an employer’s benefits team about benefit choices at open enrollment. A telehealth provider cannot promise to add a benefit that the plan excluded.

Your clinician can evaluate whether a separate FDA-approved indication genuinely applies, but do not invent a diagnosis or assume clinical suitability establishes payment. If you already have a prescriber and a suitable prescription, compare direct manufacturer self-pay options without adding a care membership you do not need. Confirm the exact product, dose, eligibility, and price before filling. Provider help is another option when you actually need clinical care; see the fit and cost tradeoff below.

Government-program rules differ from commercial Choice criteria even if Prime processes the claim. For Medicare, ask your Part D plan and clinician about indication-specific coverage and the separate Medicare GLP-1 Bridge. Use the detailed Medicare GLP-1 Bridge guide for eligibility, current program rules, and how to apply rather than assuming a commercial PA qualifies you.

Medicaid coverage depends on your state, benefit, and indication. Check your state’s current policy and managed-care plan; our Medicaid Wegovy guide explains the questions to ask. This merger does not reverify every government-program policy.

Cardiovascular-risk reduction and MASH are separate indication pathways for appropriate patients, not shortcuts around a weight-loss exclusion. Your treating clinician must establish the diagnosis and suitable product, while your plan decides payment. See the Wegovy heart-disease PA guide for more detail. MASH requires liver-disease assessment and indication-specific records; talk with the treating clinician or specialist rather than using this coverage guide to self-diagnose.

Ro may fit someone who needs clinician-led GLP-1 care and wants help with insurance paperwork. Its paid insurance concierge is distinct from its free coverage checker: benefits verification and PA support are services, not approval guarantees. The free checker does not prescribe or submit treatment requests and does not check Wegovy tablets.

The bundle’s October 1, 2026 check of Ro’s pricing page found $39 for the first membership month, then $74–149 per month by plan. The $74 rate requires annual prepayment; $149 is the monthly plan. Medication is billed separately. These are provider-published membership prices, not a verified patient bill or insurance copay.

Ro’s insurance-support restrictions documented in the keeper’s June research were commercial insurance and FEHB, not Medicare, Medicaid, or TRICARE; confirm current support for your exact plan before paying. If you have government coverage, start with the plan/program and your prescriber. If your existing doctor can correct the form, that may avoid a membership entirely. If the category is excluded, paying for a concierge does not establish coverage.

Affiliate link. Commercial insurance and FEHB support were documented in June; confirm eligibility and current restrictions directly.

For self-pay care, compare what is included, not just the advertised starting amount. Provider order remains Ro, then Sesame: Ro offers a membership-based care route; Sesame offers clinician choice and visit/care options. Sesame’s prior price was not reverified for this merger. Compare each current care charge plus the separate medication bill, or use an existing prescriber and the direct manufacturer route.

Both are affiliate links. FDA-approved options only — not compounded alternatives. Confirm current terms and clinical availability.

The RX Index Editorial Team compares published policies and provider information. We did not test a patient’s coverage, obtain a prescription, buy medication, or observe an approval outcome. This is source-based editorial research, not a clinician review or individual coverage determination.

• Prime Choice commercial weight-management PA and quantity-limit PDF — effective July 1, 2026; targeted bundle check October 1, 2026. The document covers a particular commercial program and warns that coverage and formularies vary by benefit plan.
• MyPrime drug information — member tool retained from the keeper’s June 2, 2026 research. Your card’s pharmacy-benefits line is the direct coverage contact; we did not check a member’s account.
• Wegovy prescribing information — manufacturer-hosted primary reference for indications, contraindications, and warnings. Medical statements are retained from the keeper’s June research, not a new clinical review. Discuss the current label and your health history with your prescriber.
• Ro free GLP-1 Insurance Coverage Checker (sponsored affiliate link, opens in a new tab) — targeted bundle check October 1, 2026: supported autoinjector pens; no Wegovy pill check, treatment submission, or prescription during the free check.
• Ro pricing (sponsored affiliate link, opens in a new tab) — targeted bundle check October 1, 2026: $39 first membership month, then $74–149/month by plan; annual prepayment for $74, monthly plan $149, medication extra.
• NovoCare manufacturer pharmacy and self-pay information — retained from June 2 research as a direct place to check current terms. Medication prices and savings amounts were not reverified for this merger.
• CMS Medicare GLP-1 Bridge — source retained from June 2 research; this merger does not refresh all government-program criteria. Follow the detailed linked guides and CMS for current eligibility.

• Does Prime Therapeutics cover Mounjaro? →
• Does Aetna cover Wegovy? →
• Does Cigna cover Wegovy? →
• Medicare GLP-1 Bridge: full guide →